To support the early diagnosis and life changing, early treatment of diseases, we’ve developed a series of rapid, point-of-care diagnostic tests. With just a finger stick or oral fluid sample, our tests can provide a valid diagnosis for multiple diseases, including:

• Type 1 diabetes
• Type 2 diabetes
• Gestational diabetes
• Preeclampsia
• Rheumatoid arthritis
• Lupus (coming in 2025)
• MS (coming in 2025)
• Bird flu (coming in 2025)

Adding these rapid tests to other clinical information means doctors can more quickly, easily and cost effectively manage their patients. Early diagnosis is often key in implementing early treatment protocols, monitoring  the progression of the disease and supporting a patient’s health and quality of life. In addition to accurate risk assessment, our point-of-care tests are also more affordable. When paired with our QReader smart device technology, the point-of-care tests can save you lab time and costs, while delivering results in 15 minutes or less.